This complimentary, 60-minute webinar will feature thought leader Dr. Xinglong Zheng, Chair of the Department of Pathology and Laboratory Medicine at the University of Kansas Medical Center, in a conversation with Mr. George A. Fritsma about von Willebrand factor, including new treatments and management of trauma.
BioMedica Diagnostics, Inc. is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
Time: Tuesday, January 26, 2021 5:00 PM - 6:00 PM EST (UTC / GMT - 22:00:00)
Xinglong Zheng, MD, PhD
Dr. Zheng is a Professor and the Russell J. Eilers, MD Endowed Chair of the Department of Pathology and Laboratory Medicine at the University of Kansas School of Medicine. Dr. Zheng received his MD from Nanchang University, his PhD from University of Vienna, and served his residency at Barnes-Jewish Hospital, Washington University. Dr. Zheng served on the faculty of the University of Pennsylvania, then as the University of Alabama at Birmingham Robert B. Adams Professor and Division Director of Laboratory Medicine. Dr. Zheng is an NIH-sponsored investigator and expert in the diagnosis and management of thrombotic thrombocytopenic purpura (TTP). Dr. Zheng was among the first scientists who identified and cloned ADAMTS13, a critical enzyme involved in TTP. Dr. Zheng has published more than 100 manuscripts in peer-reviewed journals, four book chapters, and chaired the first International Society on Thrombosis and Haemostasis (ISTH) committee to develop guidelines for TTP diagnosis and management. Dr. Zheng has trained dozens of graduate students, postdoctoral fellows, scientists, and physician scientists, most of whom have gone on to establish academic careers.
George A. Fritsma, MS, MLS
George consults for the Laboratory Medicine Division of the Pathology Department, University of Alabama at Birmingham School of Medicine, and is an Associate Professor with Michigan State and Rutgers Universities. He is a consulting editor for the Clinical Laboratory Science journal and contributing author for Rodak’s Hematology, Elsevier, published 2020. He is also scientific advisor for BioMedica Diagnostics, Inc. George holds a Bachelor of Science degree in biology and chemistry from Calvin University, and a Master’s in Medical Laboratory Science from Wayne State University. He provides resources and education through his blog, The Fritsma Factor, Your Interactive Hemostasis Resource, www.fritsmafactor.com.
This webinar has been supported by an educational grant from BioMedica Diagnostics, Inc., a member of the Scotia Investments family of companies.